Patient receiving cancer care at Memorial Sloan Kettering Cancer Center.

People Treated for Cancer at MSK Live Better, Longer1

Award-Winning Excellence, Year After Year

Independent rankings and expert evaluations recognize MSK each year as a world leader in patient-centered cancer care and research.

Find Cancer Types and Conditions

Understand your diagnosis and learn how MSK experts provide personalized cancer care.

Here for Every Step Forward

At MSK, you will never navigate cancer alone. Our Care Teams will help guide you through each step.

Researcher using advanced laboratory technology to develop new cancer treatments.

Innovating with Impact

Discoveries made in our labs lead to new treatments that improve outcomes and change lives for patients at MSK and around the world.

Emerging researchers learning laboratory techniques to advance the future of cancer care.

The Future of Oncology

Training the next generation of leaders in cancer care and research is central to our mission. MSK provides hands-on mentorship and world-class education that prepares emerging scientists and clinicians for the future.

MSK News and Discoveries

Dr. Eileen O'Reilly seen smiling in an exam room.
Clinical Trial News & FDA Approvals
How Daraxonrasib Could Improve Pancreatic Cancer Treatment, Offering New Hope

Learn how a successful clinical trial for pancreatic cancer in which MSK experts play a leading role is opening a new world of treatment options.

Black male patient smiling and talking to cancer doctor.
New Cancer Treatments & Patient Stories
Black Men Face Higher Prostate Cancer Risks — Early Detection Is Essential

Read how prostate cancer screening saved a man's life and inspired his activism for cancer awareness in the Black community. 

A hand points to brain images on a screen.
New Cancer Treatments & Patient Stories
Treating Cancer When It Spreads to the Brain

MSK doctors and scientists are leading the charge to find new and innovative ways to treat metastatic brain cancer.

1Based on Medicare patient data adjusted survival rate for all cancers combined when compared to all National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers.